Lun-Jie Yan

6PUBLICATIONS
21CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersHaematological tumoursDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 31, 2025
Hypoxia-Induced Creatine Uptake Reprograms Metabolism to Antagonize PARP1-Mediated Cell Death and Facilitate Tumor Progression in Hepatocellular Carcinoma.

Rui-Zhe Li, Guo-Qiang Pan, Chen Xiong

|Apr 30, 2024
Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysis.

Qi-Hang Cao, Hui Liu, Lun-Jie Yan

|Apr 16, 2024
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Cheng-Long Han, Bao-Wen Tian, Lun-Jie Yan

|Nov 06, 2023
Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis.

Han Li, Hui Liu, Lun-Jie Yan

|Oct 28, 2022
Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis.

Lun-Jie Yan, Sheng-Yu Yao, Hai-Chao Li

|Jan 04, 2021
Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysis.

Zi-Niu Ding, Zhao-Ru Dong, Zhi-Qiang Chen

Pageof 1

Frequent Collaborators

5 joint publications

Tao Li

3 joint publications

Zhao-Ru Dong

2 joint publications

Zhi-Qiang Chen

2 joint publications

Zi-Niu Ding